{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Donato Paolo Mancini", "title": "EU delays approval of Novavax's revised Covid jab - Financial Times", "description": "US biotech has been struggling to overcome fall in demand for coronavirus jabs", "url": "https://www.ft.com/content/2e10b2ab-7d0c-48a3-b49b-8de8dc302c6d", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252Fc9b25c15-a093-40f3-9f88-bf24f741d9bf.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-10-15T04:00:36Z", "content": "EU regulators have delayed a decision to approve Novavaxs variant-tailored Covid-19 vaccine, in a setback for the US-listed biotech which is battling a slump in demand for coronavirus jabs.\r\nThe Euro\u2026 [+2445 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Matt Tracy", "title": "Ripple effect seen on markets globally from Middle East conflict - Reuters", "description": "Economists and market strategists are anticipating further ripple effects globally from the Middle East conflict, watching to see if the situation draws in other countries with the potential to increasingly drive up oil prices and send capital flowing to safe\u2026", "url": "https://www.reuters.com/markets/ripple-effect-seen-markets-globally-middle-east-conflict-2023-10-15/", "urlToImage": "https://www.reuters.com/resizer/O6u1rgvuoJLkjcAMv3JEjECJCN8=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/EOZYYCLCMZLOZDEIGWSOQ7MXIU.jpg", "publishedAt": "2023-10-15T04:00:27Z", "content": "WASHINGTON, Oct 15 (Reuters) - Economists and market strategists are anticipating further ripple effects globally from the Middle East conflict, watching to see if the situation draws in other countr\u2026 [+2482 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Hannah Kuchler", "title": "Novo Nordisk raises profit guidance as weight-loss drug sales boom - Financial Times", "description": "Danish drugmaker behind Wegovy and Ozempic has become Europe\u2019s biggest company", "url": "https://www.ft.com/content/e7200651-8659-4c3b-8913-a9e3486f0a5b", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F314f62d1-0043-4a8e-82c7-11a6c1a33185.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-10-13T14:01:59Z", "content": "Soaring sales of weight loss and diabetes drugs Wegovy and Ozempic have pushed Europes largest company Novo Nordisk to raise its full-year revenue and profits guidance.\r\nThe Danish drugmaker now expe\u2026 [+2198 chars]"}]}